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The asymmetric organocatalytic transfer hydrogenation of imines can be accomplished in good
yields with high enantioselectivities through the use of BINOL-derived phosphoric acids as
catalysts and Hantzsch esters or benzothiazoles as the hydride source. The same method can also
be applied to the enantioselective reduction of benzo-fused heterocycles, such as quinolines,
benzoxazines, benzothiazines, benzoxazinones, quinoxalines, quinoxalinones and a limited number
of pyridines containing electron-withdrawing groups. Cascade reactions involving multiple
reductions and rearrangements have been reported as well as combinations of metal-catalysed
reactions, such as gold-catalyzed hydroaminations of alkynes combined with the reduction of the
ensuing enamine. Although turnover frequencies of the organocatalytic imine hydrogenations are
still lower than those of metal-catalyzed hydrogenations, there are several advantages. Mild and
environmentally friendly conditions as well as excellent selectivity make this method a valuable
approach to enantiopure amine building blocks.
Introduction
Although the eﬃciency and selectivity of many organo-
catalytic reactions meets the standards of established organic
reactions,1 use of metal catalysts often leads to higher turnover
frequencies in the asymmetric hydrogenation of imines
compared to the use of organocatalysts. However, to the best
of our knowledge there is no metal catalyzed asymmetric imine
hydrogenation as part of an industrial process with the
exception of the Metolachlor process.2 There are several
disadvantages of metal catalysts that often preclude industrial
applications. These are related to the cost of the catalyst,
relatively low turnover numbers—the Metolachlor process is
an exception—and possible contamination of the product with
metals. Organocatalytic reactions have several advantages;
they can be performed under aerobic conditions, organo-
catalysts are also more stable than enzymes and can be
anchored to a solid support and reused more conveniently than
organometallic/bioorganic analogues. Organocatalysts also
oﬀer alternatives with respect to the activation of the substrate.
Although organocatalytic reactions have passed through a
ﬂourishing decade, their origins started much earlier.3
Organocatalytic hydride transfers are inspired by reduction
processes in nature.4 In biological systems, reductions are
done in the cascade reactions using enzymes and organic
hydride reduction cofactors, such as nicotinamide adenine
dinucleotide (NADH) and ﬂavin adenine dinucleotide
(FADH2). The ﬁrst metal-free enantioselective imine
reduction was reported in 1989 by Singh and Batra.5 With
the use of amino acids as catalysts and Hantzsch esters (HE)
as hydrogen sources, up to 62% ee was obtained. Hantzsch
esters are bio-inspired hydride donors, commonly known as
synthetic analogues of reduced nicotinamide adenine dinucleotide
(NADH).6
Over the last decade, Brønsted acids have become a success-
ful alternative to metal catalysts.7 Brønsted acid catalysis relies
on enantioselective protonation or formation of a directed
hydrogen bond by the catalyst. The interaction between the
catalyst and the substrate is noncovalent and the chiral ion
pair is the active species. Fig. 1 represents phosphoric acid
catalysts and Hantzsch esters that have been successfully
employed in the organocatalytic transfer hydrogenation of
imines over the last 5 years.
N-Aryl imines
In 2005, Rueping et al. reported the ﬁrst enantioselective
Brønsted acid catalyzed reduction of N-aryl ketimines8,9 using
a phosphoric acid catalyst derived from the Akiyama–Terada
family of BINOL-derived catalysts (Scheme 1).10 Hantzsch
ester 6 was used as the hydrogen source and various
BINOL-derived 3,30-aryl-substituted phosphoric acids were
screened. Both steric and electronic eﬀects of the substituents
on the BINOL backbone were shown to inﬂuence the
asymmetric induction. A strong solvent eﬀect was observed,
with non-polar solvents such as benzene leading to the best
enantioselectivity and yield. Using 20 mol% of Brønsted acid
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1a N-aryl ketimines 9 were reduced with up to 84% ee and
good yields.
Rueping proposed a mechanism in which the ketimine is
activated by protonation through Brønsted acid 1a, which
generates the iminium compound A (Scheme 1). Subsequent
hydrogen transfer from the Hantzsch ester 6 yields a chiral
amine and pyridinium salt B, which undergoes proton transfer
to regenerate the Brønsted acid 1a. The authors assigned the
absolute conﬁguration of the products based on the stereo-
chemical model derived from the X-ray crystal structure of the
catalyst. They propose that in the transition state, the ketimine
is activated by the Brønsted acid 1a, favouring the nucleophile
to approach the substrate from the less hindered si face. The re
face is shielded by the aryl group of the catalyst.
List et al. reported independently the use of only 1 mol% of
the (S)-BINOL-derived phosphoric acid 1b and Hantzsch ester
6 as the hydrogen source in the transfer hydrogenation of
N-PMP-protected aromatic and aliphatic ketimines, with up
to 93% ee and high yields.11 Moreover, imine generation could
be performed in situ in the presence of molecular sieves.
After the subsequent deprotection with CAN (cerium(IV)
ammonium nitrate), the primary amine was isolated with
88% ee and 81% yield. Following these results reported by
Rueping et al.8,9 and List et al.11 several groups reported
BINOL-derived phosphoric acids to lead to excellent results
in the metal-free transfer hydrogenation of the CQN bond.
The steric hindrance in the 3,30-position was shown to play an
important role in the asymmetric induction.
Enantiomerically pure a-amino acids and their derivatives
are the building blocks for the synthesis of peptides and chiral
pharmaceuticals.12 One straightforward approach to the
synthesis of enantiopure a-amino acids is the asymmetric
hydrogenation of a-imino esters. Antilla and co-workers13
and You and co-workers14 reported the organocatalytic
asymmetric transfer hydrogenation of N-PMP protected a-imino
esters 11 and 13 using chiral phosphoric acids as a catalyst and
Hantzsch esters as the hydrogen source (Scheme 2).
Using 5 mol% of the VAPOL-derived catalyst 4 Antilla
et al.13 found excellent enantioselectivities and yields in the
hydrogenation of a-aryl and a-alkyl substituted imino esters
11 (up to 99% ee). The use of in situ prepared imino esters gave
lower overall yields, however with identical enantioselectivities.
You et al.14 reported the use of 1 mol% of the hindered
9-anthracenyl-substituted phosphoric acid (S)-1c which
resulted in excellent yields and ee’s (up to 98% ee). Enantio-
selectivities were strongly dependant on the 3,30-substituents
on the phosphoric acid catalyst and the ester group of the
substrate. The more bulky the ester group was, the higher the
enantioselectivity.
Antilla and co-workers described a highly enantioselective
hydrogenation of aromatic enamides catalyzed by phosphoric
Fig. 1 Most successful phosphoric acid catalysts and Hantzsch esters
employed in the organocatalytic transfer hydrogenation of imines.
Scheme 1 Rueping’s organocatalytic reduction of imines and the
proposed mechanism.
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acid (S)-1c. The authors found it was possible to speed up the
reaction substantially by the addition of 10 mol% of acetic
acid. A range of aromatic enamides was reduced with ee’s
ranging from 41–95% ee. Apparently, the hydrogenation
proceeds through the protonated iminium intermediate.15
You et al. reported the asymmetric transfer hydrogenation
of N-PMP-substituted b,g-alkynyl a-imino esters 15 using
1 mol% of Brønsted acid 1c. Both the alkyne and imine
moieties were reduced with Hantzsch ester 6 to aﬀord trans-
alkenyl a-amino esters with up to 96% ee (Scheme 3).16 Yields
were moderate and highly dependant on the variation of the
ester group of the substrate, while enantioselectivity was
unaﬀected. Mechanistic investigation showed that the
reduction of the carbon–carbon triple bond is faster than that
of the imine bond.
Recently, Zhu and Akiyama reported the use of benzo-
thiazolines 17 and 21 as hydrogen donors in the asymmetric
transfer hydrogenation of N-PMP-protected ketimines17 9 and
a-imino-esters 10 (Scheme 4).18 With the use of up to 2 mol%
of 3,30-disubstituted-BINOL-derived phosphoric acid catalyst
1b, excellent yields and enantioselectivities were achieved.
Once again both the yields and enantioselectivities were
dependant on the substituent in the 3,30-position of the
BINOL backbone of the catalyst.
Akiyama has shown that benzothiazolines can be generated
in situ. Introduction of a hydroxy group onto the benzothiazoline
as in 21 leads to the formation of benzothiazole 22 that precipi-
tates from the reaction mixture. Thus, 22 is easily removed by
ﬁltration, which simpliﬁes the ensuing puriﬁcation of the product.
This is the major advantage over the use of the Hantzsch esters.
Gue´ritte and co-workers developed a protocol for the
enantioselective transfer hydrogenation of unprotected ortho-
hydroxyaryl alkyl N–H imines 23 using 10 mol% of (S)-1e as a
catalyst and Hantzsch ester 7 as the hydride source. A variety
of ortho-hydroxybenzylamines was obtained with good to
excellent yields and enantioselectivities (Scheme 5).19
Nitrogen heterocycles
Rueping has reported the organocatalytic cascade transfer
hydrogenation of nitrogen heterocycles. Brønsted acid
catalyzed cascade transfer hydrogenation of quinolines,20
quinoxalines,21 pyridines,22 benzoxazines, benzoxazinones
and benzothiazines23 provides direct access to valuable enantio-
enriched saturated heterocyclic compounds that are of
considerable importance as intermediates for pharmaceuticals
and agrochemicals and for use in the material sciences.24
In the reduction of 2-substituted quinolines 25, enantio-
selectivities of 499% ee were obtained using 2 mol% of
catalyst 1d (Scheme 6). In general, 2-substituted quinolines
with aromatic, heteroaromatic and aliphatic substituents were
well tolerated. This is one of the ﬁrst examples of metal-free
asymmetric reduction of heteroaromatic compounds. The
method was applied to the two-step synthesis of the natural
products ()-angustureine, (+)-cuspareine and (+)-galipinine
in 90–91% ee and high yields. Rueping and Theissmann
recently reported the ﬁrst highly enantioselective Brønsted
acid catalyzed reaction in an aqueous medium.25 Various
Scheme 3 You’s organocatalytic transfer hydrogenation of b,g-alkynyl
a-imino esters.
Scheme 4 Benzothiazolines as a hydrogen source in the organo-
catalytic transfer hydrogenation of imines and imino-esters.
Scheme 5 Enantioselective transfer hydrogenation of unprotected
ortho-hydroxyaryl alkyl N–H imines.
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2-substituted quinolines and a benzoxazine were reduced using
2 mol% of 1b and Hantzsch ester 7 in brine as a solvent. Good
yields and enantioselectivities of 83–97% were obtained.
Rueping and co-workers used Brønsted acid 2 derived from
H8-BINOL as a catalyst for the enantioselective transfer
hydrogenation of 3- and 2,3-substituted quinolines 27 and
29, with good yields and enantioselectivities/diastereoselectivities
(up to 86% ee and 99% ee, respectively).26
The Brønsted acid 2 was recently used successfully by the
same authors as a catalyst in the 4-step metal-free synthesis of
the ﬂuoroquinolone antibiotic ﬂumequine and levoﬂoxacin
with high ee’s and yields.27 Whereas in the Brønsted catalyzed
enantioselective transfer hydrogenation of 2- and 4-substituted
quinolines the authors proposed that the enantioselectivity is
introduced in the hydride addition, in the case of 3-substituted
quinolines the enantiodetermining step was assumed to be the
protonation by the Brønsted acid catalyst (Scheme 7).
Du and co-workers have also reported the organocatalytic
transfer hydrogenation of quinolines (Scheme 8). As in
previous cases they showed that the steric bulk of the
substituent on the BINOL backbone of the phosphoric acid
catalysts is crucial for obtaining good reactivity and selectivity.
They employed double axially chiral phosphoric acids as
catalysts, where substituents in the 3,30-positions posses
double axial chirality.28 The use of 0.2 and 1 mol% of catalyst
5, respectively, resulted in excellent enantioselectivities,
diastereoselectivities and yields in the transfer hydrogenation
of 2- and 2,3-substituted quinolines 25 and 31 (up to 98% ee
and 92% ee, respectively).
Rueping and co-workers reported that excellent enantio-
selectivities and high yields were obtained in the reduction of
benzoxazines 33, benzothiazines 34 and benzoxazinones 37
using 0.1–1 mol% of phenanthryl-substituted BINOL-derived
phosphoric acid 1d (Scheme 9).23,29 The enantiopure dihydro-
benzoxazinones 38 could be ring opened using benzylamine to
yield the N-aryl amino acid benzylamide 39 with preservation
of stereochemical integrity.
Rueping and co-workers recently reported the ﬁrst organo-
catalytic transfer hydrogenation of 2-aryl substituted quinoxalines
40 and quinoxalinones 42, with the use of up to 10 mol% of
the Brønsted acid 1c and Hantzsch ester 6 as the hydride
source.21 Enantioselectivities were high for both classes of
substrates, with good to excellent yields (Scheme 10). The
authors proposed a mechanism in which, similar to their
previously reported quinoline reductions, the substrate is
activated through Brønsted acid catalyzed protonation,
followed by double 1,2-hydride addition.8
Rueping and Antonchick also reported the ﬁrst Brønsted
acid catalyzed cascade reduction of pyridines.22 With the use
of 5 mol% of the phosphoric acid 1c various azadecalinones
45 and tetrahydropyridines 47 were obtained in good yields
and excellent enantioselectivities (Scheme 11).
Enantioselectivity was highly dependant on the substituent
on the phosphoric acid catalyst and the ester group of the
Hantzsch ester. The authors also applied their method to the
Scheme 7 Proposed mechanism for the asymmetric transfer hydrogenation of quinolines using chiral phosphoric acids.
Scheme 8 Du’s organocatalytic transfer hydrogenation of quinolines.
Scheme 9 Rueping’s organocatalytic transfer hydrogenation of
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synthesis of the alkaloid diepi-pumiliotoxin C. The proposed
mechanistic cycle of the transfer hydrogenation of pyridines
starts with the protonation of the pyridine by the phosphoric
acid, resulting in the chiral ion pair A (Scheme 11). Subsequent
hydride transfer from Hantzsch ester 6 gives the adduct B,
which is transformed into the iminium ion C through an
acid-catalyzed isomerization. A second hydride transfer results in
the desired product, and the phosphate catalyst 1c is regenerated.
The same authors developed a protocol for the enantio-
selective transfer hydrogenation of 3H-indoles 48.30 Using
1 mol% of 1c as catalyst, various substituted indolines were
isolated with high yields and 70–99% ee (Scheme 12).
Recently, Rueping and co-workers described the asymmetric
organocatalytic hydrogenation of quinolines and benzoxazines
using polymer-supported chiral BINOL-derived phosphoric
acids.31 These catalysts were shown to be as stable and
eﬀective as their homogenous counterparts and could be easily
removed from the reaction mixture and reused in up to
11 consecutive reactions with preservation of both enantio-
selectivity and reactivity.
In 2008, Metallinos et al. described the ﬁrst asymmetric
organocatalytic transfer hydrogenation of 2- and 2,9-substituted
1,10-phenantrolines 50 (Scheme 13).32 They applied ‘‘Rueping’s
conditions’’; using up to 10 mol% of the phosphoric acid
catalyst 1d and 1f and Hantzsch ester 6 (6 eq.) and obtained
octahydrophenantrolines 51 in 40–88% yield and good to
excellent enantioselectivites (78–99% ee).
Rueping and co-workers recently reported the highly
enantioselective synthesis of benzodiazepinones via organo-
catalytic transfer hydrogenation.33 A one-pot procedure
involving the in situ generation of benzodiazepin-2-ones 52
and subsequent hydrogenation furnished benzodiazepinones
53 in moderate to high yields and excellent enantioselectivities
(83–99% ee, Scheme 14).
Gong and co-workers described a dynamic kinetic transfer
hydrogenation of 2-methyl-2,4-diaryl-2,3-dihydrobenzo[b][1,4]
diazepines with 8 using the 3,30-phenyl-substituted BINOL-
derived phosphoric acid catalyst.34 Using 10 mol% of the
catalyst at 10 1C, optically active 1,3-diamines were isolated
with high yields and moderate to good diastereoselectivities
(2 : 1 to 8 : 1; syn is the major isomer) and good enantio-
selectivities (63–86% ee).
Direct reductive amination
The direct reductive amination is a biomimetic reaction that
allows the asymmetric coupling of complex fragments
Scheme 10 Rueping’s organocatalytic transfer hydrogenation of
quinoxalines and quinoxalinones.
Scheme 11 Rueping’s organocatalytic reduction of pyridines and the
proposed mechanism.
Scheme 12 Rueping’s organocatalytic reduction of indoles.
Scheme 13 Asymmetric organocatalytic transfer hydrogenation of
1,10-phenantrolines.
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containing a ketone functionality into amines by the use of a
chiral hydrogen-bonding catalyst and a hydrogen donor.
Direct reductive amination enables access to enantio-enriched
amines without the isolation of the imine substrates. This is a
great advantage in the case of imines that are too unstable to
be isolated.
The ﬁrst enantioselective organocatalytic direct reductive
amination was described by MacMillan and co-workers in
2006 (Scheme 15).35 They were able to achieve the reductive
amination of aromatic and aliphatic ketones with various
aromatic and heteroaromatic amines. Exposing ketone 54
and amine 55 to 10 mol% of the chiral catalyst 1e, in the
presence of molecular sieves, resulted in the formation of an
intermediate iminium species that in the presence of a suitable
Hantzsch ester underwent enantioselective hydride reduction
with excellent enantioselectivities and moderate to good yields.
Based on the X-ray structure of the catalyst, as well as on
calculated and experimental data, the authors concluded that
the catalyst is particularly selective for the reduction of
iminium ions derived from methyl ketones. Ethyl ketones
reacted substantially slower. Remarkably, aliphatic methyl
ketones could also be reductively aminated with a variety of
anilines with ee’s between 83–94%. List and co-workers
described the asymmetric Brønsted acid catalyzed reductive
amination of ketones using benzylamine. With the use of
5 mol% of (S)-1c moderate to good yields and enantio-
selectivities were obtained with four diﬀerent substrates
(26–88% ee).36 Reactions were slow and took 7 days.
The scope of the organocatalytic direct reductive amination
was extended by List and co-workers to a-branched aldehydes37
and ketones (Schemes 16 and 17).38 Enolizable a-branched
aldehydes were subjected to direct reductive amination to give
b-branched amines via an enantiomer-diﬀerentiating kinetic
resolution.
Under reductive amination conditions the a-branched
aldehyde 57 undergoes a fast racemization in the presence of
the amine and an acid catalyst via an imine/enamine tauto-
merization. The reductive amination of one of the two imine
enantiomers is faster than that of the other, resulting in an
enantiomerically enriched product via a dynamic kinetic
resolution (DKR).
Using 5 mol% of catalyst 1b and Hantzsch ester 7 as a
hydrogen source diﬀerent aryl, alkyl-substituted aldehydes
were reduced to b-branched amines 58 with up to 98% ee
and high yields. Aliphatic aldehydes can also be employed
although with lower enantioselectivity.
This approach was extended to the ﬁrst example of the
direct catalytic asymmetric reductive amination of a-branched
ketones using DKR (Scheme 17).38 Treating cyclohexanones
59 with para-anisidine 60, Hantzsch ester 6 and Brønsted acid
1d provided 2-alkyl, 2-aryl and 2-chloro-substituted
N-PMP-protected cyclohexylamines 61 in good to excellent
diastereo- and high enantioselectivity. The catalyst loading
used depended on the steric demand of the substituent
(1–10 mol%). Ketones with diﬀerent ring sizes gave less
successful results. Whereas 2-substituted cyclopentanone
underwent reductive amination with lower selectivity, cyclo-
heptanone did not undergo reductive amination. This
approach was successfully used for the preparation of a key
intermediate for the synthesis of Perindopril, an ACE inhibitor.39
Enders and co-workers recently reported the organo-
catalytic asymmetric synthesis of trans-1,3-disubstituted
tetrahydro-isoquinolines via a reductive amination/aza-
Michael reaction sequence (Scheme 18).40 When methylketone
enoates 62 and 64 were subjected to the reductive amination
conditions using 10 mol% of the Brønsted acid 1b and
a hydride source (Hantzsch ester or benzothiazole) in the
Scheme 15 MacMillan’s organocatalytic direct reductive amination.
Scheme 16 Organocatalytic reductive amination of a-branched
aldehydes by DKR.

















































This journal is c The Royal Society of Chemistry 2011 Catal. Sci. Technol., 2011, 1, 727–735 733
presence of p-anisidine and molecular sieves, the amines 63
and 65 were obtained with high yields and enantioselectivities.
Use of the benzothiazole reductant 66 resulted in higher yields
and enantioselectivities when compared with the use of the
Hantzsch ester. Treating the resulting amines with strong
bases induced the cyclization reaction, resulting in the trans-
diastereomer of the tetrahydro-isoquinoline product in good
yields. Starting from an indole-derived keto enoate 64 the
corresponding trans-disubstituted b-carboline 65 was obtained
in excellent yield and stereoselectivity.
Recently Akiyama et al. reported the use of BINOL-derived
phosphoroselenoic acids as organocatalysts in the imine
hydrogenation and direct reductive amination of acetophenone,
with up to 62% ee.41 The ﬁrst nucleotide-catalyzed reductive
amination of acetophenone, using the Hantzsch ester as the
hydrogen donor, was described by Kumar and co-workers.
With the use of up to 5 mol% of catalyst, they were able to
obtain the products in good yields with up to 79% ee.42
Domino reactions
Over the last few years, organocatalytic domino reactions
attracted signiﬁcant attention.43 In nature, enzymatic multi-
step sequences often take the form of domino and multi-
component reactions. As the advantage of the formation of
several bonds in a single reaction is evident, many groups have
pursued organocatalytic domino reactions. In particular,
amines and their salts trigger cascade reactions via enamine
and/or iminium ion formation. The ﬁrst example of an
enantioselective phosphoric acid catalyzed domino reaction
was the enantioselective cascade transfer hydrogenation of
quinolines established by Rueping et al. mentioned earlier.20
In 2007, List et al. reported a domino reaction involving a
Brønsted acid catalyzed transfer hydrogenation (Scheme 19).44
The authors combined enamine and iminium catalysis with
asymmetric Brønsted catalysis in order to obtain pharma-
ceutically relevant cis-1,3-substituted cyclohexylamines 68 in
high diastereo- and enantioselectivities, starting from linear
diketones 67. The reaction proceeds via an intramolecular
aldol condensation followed by a conjugate reduction and
reductive amination cascade that is catalyzed by a Brønsted
acid 1b and accelerated by the amine substrate. The authors
proposed a catalytic cycle that was recently veriﬁed by mass
spectrometry.45 The initial aldolization step involves forma-
tion of the enamine A, which reacts intramolecularly to form
the iminium salt B. B undergoes conjugate reduction to C and a
ﬁnal reduction thereof furnishes the cyclohexylamine product 68.
Rueping and co-workers developed an asymmetric organo-
catalytic cascade reaction in which multiple steps are catalyzed
by a chiral Brønsted acid catalyst 1c and which provides
tetrahydropyridines and aza-decalinones with good yields
and excellent enantioselectivities (Scheme 20). The sequence
comprises a one-pot Michael addition–isomerization–cyclization–
elimination–isomerizaton–transfer hydrogenation in which
each step is catalyzed by the same chiral Brønsted acid.46
The authors propose a mechanism in which exposure of a
mixture of enamine 69 and vinyl ketone 70 to catalytic
amounts of the Brønsted acid leads to the formation of the
corresponding 1,4-addition products 72 and 73. Subsequent
Brønsted acid catalyzed cyclization of 72, which is in an acid-
catalyzed equilibrium with 73, gives the hemiaminal 74 which
upon rapid water elimination results in the formation of the
dihydropyridine 75. The following Brønsted acid catalyzed
protonation isomerizes the enamine to the iminium ion 76,
which is activated for an enantioselective hydride transfer to
give the desired product. The requirement is that the last
Brønsted acid catalyzed step in the sequence proceeds with
high enantiocontrol. This domino reaction consists of six
reaction steps catalyzed by the same catalyst which represents
a direct and eﬃcient access to useful tetrahydropyridines and
azadecalinones from simple and readily available starting
materials with the highest levels of enantiocontrol.
Scheme 18 Synthesis of trans-1,3-disubstituted tetrahydroisoquino-
lines via a reductive amination/aza-Michael reaction sequence.
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The concept of combining metal catalyzed reactions with
organocatalysis has emerged as a promising ﬁeld since it
enables transformations that previously could not be
achieved.47 The challenge is to ﬁnd reaction conditions suitable
for the optimal performance of both metal-catalyzed and
organocatalytic steps in one pot. A hydroamination/transfer
hydrogenation cascade reaction reported by Gong and
co-workers involved conversion of 2-(2-propynyl)aniline
derivatives to tetrahydroquinolines (Scheme 21).48 The reaction
is initiated by a gold catalyzed hydroamination-cyclization to
quinoline, which is then hydrogenated with the use of
Brønsted acid catalyst 1d to give the tetrahydroquinolines 81
with excellent yield and enantioselectivities. Catalysts
tolerated both aryl and alkyl substituents on the propynyl
bond, with the alkyl substituents leading to somewhat lower ee’s
(87–88% ee compared to 94–99% in case of aryl substituents).
The silver salt of the Brønsted acid was also prepared and tested,
but its use led to poor reactivity (35% yield, 90% ee, 80 h).
The authors therefore concluded that the stereochemistry was
controlled by the phosphoric acid. This method is nicely
complimentary to the direct reduction of 2-substituted quinolines
as described above in view of the diﬀerent starting materials.
Che independently reported a highly enantioselective synth-
esis of chiral secondary amines by gold/chiral Brønsted acid
catalyzed tandem intermolecular hydroamination and transfer
hydrogenation reactions of alkynes 83, in good to excellent
yields and excellent enantioselectivities (Scheme 22).49
The authors proposed a mechanism which involves the
gold(I)-catalyzed intramolecular hydroamination of the alkyne
to generate the ketimine intermediate and the subsequent
chiral phosphoric acid catalyzed transfer hydrogenation
thereof. The authors revealed that in the presence of AuI the
hydroamination reaction proceeds smoothly, whereas in the
presence of only the Brønsted acid the hydroamination is
completely inhibited. Although AuI complexes can catalyze
the transfer hydrogenation of imines, the transfer hydrogena-
tion only takes place if the Brønsted acid is present. Control
experiments showed that upon treatment of the gold catalyst
with the chiral gold phosphate, similar reactivity and enantio-
selectivities were observed. Thus the authors claim that there is
a possible exchange of the metal counter ion, leading to the
formation of a AuI complex cation/chiral counter ion pair
which carries out the subsequent reaction. Comparing this
method to the redcution of the preformed imine or the direct
reductive amination the only disadvantage is the accesibility of
starting alkynes. Whereas the susbtituted aceophenones are
readily available, the aromatic alkynes need to be prepared via
a Sonogashira reaction.
Conclusions
The ﬁeld of organocatalytic transfer hydrogenation has been
developing at an extraordinary pace over the last decade.
Although turnover frequencies of the organocatalytic imine
hydrogenations are still lower than those of metal-catalyzed
Scheme 20 Mechanism of Rueping’s Brønsted acid catalyzed domino
reaction sequence.
Scheme 21 Asymmetric synthesis of tetrahydroquinolines via an
intramolecular hydroamination/asymmetric transfer hydrogenation
domino reaction.
Scheme 22 Asymmetric synthesis ofN-aryl imines via an intermolecular
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hydrogenations, there are several advantages. Mild, environmen-
tally friendly conditions such as the avoidance of the use of high
pressure hydrogenation conditions make this method syntheti-
cally useful. The challenges, such as the issue of the catalyst
recycling, lowering the amount of catalyst, the reduction of
reaction times and the complexity of the catalyst synthesis,
remain to be overcome to allow large-scale application.
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